메뉴 건너뛰기




Volumn 15, Issue 3, 2003, Pages 327-338

Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells

Author keywords

AKT; Cancer cell signalling; FAK; HMG CoA reductase inhibitor; Microarray; RhoA; ROCK

Indexed keywords

ACTIN; CERIVASTATIN; CYCLIN D1; CYCLINE; ENZYME INHIBITOR; EXOENZYME C3; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTEGRIN; INTEGRIN BETA8; MYC PROTEIN; PROTEIN P19; PROTEIN P21; RHO KINASE; THROMBOSPONDIN 2; UNCLASSIFIED DRUG;

EID: 0346826281     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0898-6568(02)00124-9     Document Type: Article
Times cited : (110)

References (62)
  • 3
    • 0035212177 scopus 로고    scopus 로고
    • Mundy G.R. Bone. 29:2001;495-497.
    • (2001) Bone , vol.29 , pp. 495-497
    • Mundy, G.R.1
  • 10
    • 0028935780 scopus 로고
    • Casey P.J. Science. 268:1995;221-225.
    • (1995) Science , vol.268 , pp. 221-225
    • Casey, P.J.1
  • 17


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.